[PDF] Top 20 Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.
Has 10000 "Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis." found on our website. Below are the top 20 most common "Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.".
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.
... results in immune suppression as a consequence of the depletion of Trp [32], and following the direct effect of catabolites ...lymphocytes and increase their susceptibility to apoptosis ...IDO ... See full document
9
Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation
... activate and stimulate effective immune responses by T cells, but can also act as negative regulators of these responses and thus play important roles in immune regula- ...(VEGFR1) and/or ... See full document
10
1-Methyl-D-tryptophan potentiates TGF-β-induced epithelial-mesenchymal transition in T24 human bladder cancer cells.
... role in the maternal-fetal interface and functions to protect embryos against the maternal immune system ...macrophages, and regulatory T cells, IDO has been implicated in immune-mediated ... See full document
16
HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.
... of indoleamine 2,3 dioxygenase (IDO) expression, and dendritic cells (DC) dysfunction were often associated with AIDS disease ...progression. In this work, we investigated the effect of ... See full document
12
Working memory impairment in multiple sclerosis relapsing-remitting patients with episodic memory deficits
... using 2, then 3 and inally 4 cells, the information being presented only in one cell at a ...trial in only one cell and results must refer to calculations performed with stimuli ... See full document
7
Balance Rehabilitation Unit (BRU TM) posturography in relapsing-remitting multiple sclerosis
... variation=77-298) and the values of the MS ...tion=67-286) and the MS 3-4 group ...values and comparative analysis of the sway velocity in the ten stimulation conditions for the ... See full document
6
Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.
... improvement in T25FW was observed with similar frequency in the two shorter-term SPMS trials, although one was enriched for recent relapses (MS231) while the other was enriched for the absence of relapses ... See full document
7
Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
... with Multiple Sclerosis (MS) are unable to retain employment within 10 years from disease ...inhibition and mental flexibility may have a direct impact on the ability to maintain a ...differences ... See full document
9
Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis
... control and patient groups are given in Table ...Clinical and physical disability data for the patient group at the baseline assessment are given in Table ...1.85) and the mean number ... See full document
8
Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis
... (patients and controls) en- rolled in this study were from Belo Hori- zonte, State of Minas Gerais, Brazil, where the prevalence of MS is about 15 cases per 100,000 persons ...Disease activity was ... See full document
5
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
... evaluated in more detail as follows: (i) Visual Numerical Predictive Checks ...models and their model parameter estimates. For the observed data and each simulated dataset the following descriptors ... See full document
11
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
... DNA in cerebrospinal fluid (CSF) and peripheral blood (PB) samples collected from 55 patients with clinical and radiologically-active relapsing-remitting MS (RRMS) and 51 ... See full document
6
Arq. NeuroPsiquiatr. vol.69 número3
... (IFNβ) and glatiramer acetate (GA) were the first immunomodulators approved to the treatment of relapsing-remitting multiple sclerosis (MS) and clinically isolated ...IFNβ ... See full document
8
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
... dispersion in the form of standard deviation ...both in medi- ans (with corresponding confidence intervals) and in means (with corresponding SDs would constitute another source of ... See full document
10
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease
... than relapsing-remitting multiple sclerosis (RRMS), few studies comparing both conditions in a single center have been ...followed in the same center, from 1994 to ...p=0.0013) ... See full document
5
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
... for expression of Th1 markers and produce high levels of tumour necrosis factor (TNF)- a and IFN-c ...Disease activity in relapsing-remitting MS and in ... See full document
8
Arq. NeuroPsiquiatr. vol.73 número9
... clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Eficacy in Relapsing-Remitting ... See full document
2
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
... 4203) and written informed consent was obtained from all ...participation in this ...patients and healthy controls were of Caucasian ...EDSS and clinical parameters of disease activity ... See full document
5
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
... [39], and must therefore be combined with B1 measurements to provide accurate ...acquisition and echo planar readout as described in ...excitation and EPI readout. There was only one loop over ... See full document
9
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents
... advances in MS management. The 2011 meeting took place in Brazil and included a panel of 12 independent neu- rologists, with experience in ...drugs and pharmaco- vigilance programs was ... See full document
8
temas relacionados